AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

DORZOLAMIDE

12 registrations across 6 African markets— 8 active

Markets with DORZOLAMIDE

Recent registrations

Brand / ProductMarketHolderStatusExpires
OCUDOR
SOLUTION
🇿🇼ZimbabweFDC LIMITEDactiveDec 2027
DORZOMID
Collyre / 2%
🇹🇳TunisiaADWYAexpiredOct 2023
DORZO SP 2%
Collyre / 20 mg/ml
🇹🇳TunisiaSTERIPHARMexpiredJul 2023
ALZOR 3M
Collyre / 2%
🇹🇳TunisiaUNIMEDexpiredMar 2015
ALZOR
Collyre / 2%
🇹🇳TunisiaUNIMEDexpiredApr 2005
TIMDOPT🇿🇦South AfricaActivo Health (Pty) LtdactiveJan 1900
TRUSOPT
COLLYRE
🇲🇦Moroccoactive
GLANTRIM
Drops
🇹🇿TanzaniaATCO Laboratories Limitedactive
XOLA
collyre / 0,02
🇸🇳SenegalJAMJOOM PHARMAactive
Ocudor
Ophthalmic Solution
🇹🇿TanzaniaFDC Limitedactive
NEUDOR
collyre / 2%
🇸🇳SenegalAHAAN HEALTHCARE PVT LTDactive
LUMEDOR
Ophthalmic Solution
🇹🇿TanzaniaAXA Parenterals Limitedactive

DORZOLAMIDE in Africa — Regulatory Overview

DORZOLAMIDE is registered across 6 African markets with 12 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Tunisia, Tanzania, Senegal, Morocco and 2 more. AfricaRegulatory refreshes this data daily from official government sources.

Of the 12 registrations, 8 (67%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.